Medical Marijuana (MMJ)

Articles

A civil lawsuit filed in Arkansas by a medical cannabis patient alleges that three cannabis growers and one testing laboratory inflated the amount of tetrahydrocannabinol (THC) in numerous cannabis products.

Civil Lawsuit Accuses Arkansas' Largest Cannabis Testing Laboratory of Conspiring with Cultivators to Inflate THC Levels

Recently, the University of Oxford began an international study to examine the potential therapeutic benefits of cannabidiol (CBD) in treating psychosis or psychotic symptoms.

Cannabidiol for Potentially Treating Psychosis: International Study Launched by University of Oxford

This study, which evaluated the potential of a well-designed unidirectional aseptic processing approach to both hydrocarbon and supercritical carbon dioxide extract manufacturing, suggests that the extraction process is capable of deactivating or removing the tested microbial contaminants when highly contaminated Cannabis spp. Inflorescence is used as feed material.

From Contaminated Cannabis Material to Microbe-Free Extracts: A Real-World Test

In this interview, Abbey Roudebush, Director of Government Affairs for Americans for Safe Access (ASA), explains the goals of ASA and provides an in-depth analysis of their annual State of the States report.

Medical Cannabis Is Here and It’s Here to Stay: How Americans for Safe Access, the Nation’s Largest Member-Based Cannabis Advocacy Organization, Protects Patient Rights

In this article, regulatory requirements are explored as they are meant to create confidence that cannabis and cannabis-infused products are safe to use.

Improving Quality in Cannabis Testing Laboratories: Making ISO/IEC 17025 Work for Your Laboratory and Customers

The Cannabis Center of Excellence, Inc., Medicinal Genomics, and UMass Dartmouth  have established the Healthcare Provider Knowledge, Attitudes, Practices Related to Medical Cannabis Research Study to help better understand the experiences of healthcare providers have seen with medical cannabis.

Healthcare Provider-Focused Medical Cannabis Research Study Launched by Cannabis Center of Excellence, Medicinal Genomics, and UMass Dartmouth

In this interview, learn about Nicole DiMonda’s incredible story and Jaime Brambila’s research efforts to document her case and help the lives of other cancer patients.

Medical Cannabis as an Adjunct Therapy to  Cancer Treatment: One Patient’s Journey from Diagnosis to Remission

United Nations hold historic vote announcing cannabis's Schedule IV removal from the 1961 Single Convention on Narcotics.

United Nations Removes Cannabis from Schedule IV Category

The proceeds raised from the special Veterans Day webcast will help support the families of America's fallen military heroes.

Cannabis Science and Technology® and Cannabis Patient Care™ Raised More Than $1,500 for The Tragedy Assistance Program for Survivors (TAPS)

Welcome to the first edition of Cannabis Patient Care!